Metraipolis › archive › dc_275ca520f430

CCND3 Suppression Ameliorates β-Thalassaemia in a Murine Disease Model: A Potential Therapeutic Strategy — Europe PMC PMID:41892286

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41892286
DOI
10.3390/cells15060495
License (as archived)
solo-consultazione
Archived
2026-11-04T23:30:07.617Z
SHA-256 of the archived text
8e324b856aabd1c9f2d2b07fec3521df4749a3d5e39038aacdc237750394b3db
Stable URL of this page
https://metraipolis.com/documento/dc_275ca520f430

How to cite

CCND3 Suppression Ameliorates β-Thalassaemia in a Murine Disease Model: A Potential Therapeutic Strategy — Europe PMC PMID:41892286 — Europe PMC (en), https://europepmc.org/article/MED/41892286 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_275ca520f430 (Metraipolis archive dc_275ca520f430, sha256 8e324b856aabd1c9f2d2b07fec3521df4749a3d5e39038aacdc237750394b3db)
BibTeX
@misc{dc275ca520f430,
  title = {CCND3 Suppression Ameliorates β-Thalassaemia in a Murine Disease Model: A Potential Therapeutic Strategy — Europe PMC PMID:41892286},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41892286},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_275ca520f430; sha256 8e324b856aabd1c9f2d2b07fec3521df4749a3d5e39038aacdc237750394b3db},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41892286. Agents can read the archived copy with the MCP tool read_document.